ConductScience.org, home

Trial · NCT07881471

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Walking Speed on the 10-Meter Walk TestBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Walking speed will be assessed using the 10-Meter Walk Test and expressed in meters per second. Change will be calculated as the post-rehabilitation value minus the baseline value. Positive values indicate improved walking speed. Changes will be compared between participants with ideomotor apraxia (baseline TULIA score below 194) and those without ideomotor apraxia (baseline TULIA score of 194 or above).
SecondaryChange in Berg Balance Scale ScoreBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Functional balance will be assessed using the 14-item Berg Balance Scale. Total scores range from 0 to 56, with higher scores indicating better balance. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in Timed Up and Go Test TimeBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Functional mobility will be assessed by measuring the time in seconds required to rise from a chair, walk 3 meters, turn, walk back, and sit down. Change will be calculated as the post-rehabilitation time minus the baseline time. Negative changes indicate improved functional mobility and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in Functional Ambulation Categories ScoreBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Walking independence will be assessed using the Functional Ambulation Categories. Scores range from 0 to 5, with higher scores indicating greater walking independence. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in Functional Independence Measure Total ScoreBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Functional independence will be assessed using the 18-item Functional Independence Measure. Total scores range from 18 to 126, with higher scores indicating greater independence. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in Fugl-Meyer Assessment Lower Extremity Motor ScoreBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Lower extremity motor function will be assessed using the lower extremity motor domain of the Fugl-Meyer Assessment. Scores range from 0 to 34, with higher scores indicating better motor function. Change will be calculated as the post-rehabilitation score minus the baseline score. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Measured Gait SpeedBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Gait speed recorded by the RehaWalk system will be expressed in meters per second. Change will be calculated as the post-rehabilitation value minus the baseline value. Positive changes indicate increased gait speed. Changes will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Measured CadenceBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Cadence recorded by the RehaWalk system will be expressed in steps per minute. Change will be calculated as the post-rehabilitation value minus the baseline value. Changes will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Measured Step LengthBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Step length recorded by the RehaWalk system will be expressed in centimeters. Change will be calculated as the post-rehabilitation value minus the baseline value. Changes will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Measured Step Symmetry IndexBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Step symmetry between the paretic and non-paretic sides will be assessed using the symmetry index recorded by the RehaWalk system and expressed as a percentage, with 0% indicating perfect symmetry. Change will be calculated as the post-rehabilitation value minus the baseline value. Negative changes indicate improved symmetry and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Measured Double Support TimeBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Double support time, representing the portion of the gait cycle during which both feet are in contact with the walking surface, will be recorded by the RehaWalk system and expressed as a percentage of the gait cycle. Change will be calculated as the post-rehabilitation value minus the baseline value. Negative changes indicate improvement and will be compared between participants with and without ideomotor apraxia.
SecondaryChange in RehaWalk-Recorded Walking Distance Per SessionBaseline and after the 15th rehabilitation session or at discharge, whichever comes first (up to 5 weeks)
Walking distance completed during a single RehaWalk session will be expressed in meters. Change will be calculated as the distance in the final session minus the distance in the first session. Positive changes indicate improvement and will be compared between participants with and without ideomotor apraxia.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07881471/registered